Septerna launches with $100M series A financing

By The Science Advisory Board staff writers

January 28, 2022 -- Septerna has launched with $100 million in series A financing. The financing will enable the company to advance its emerging pipeline of novel G protein-coupled receptor (GPCR)-targeted drug programs.

In addition, the company said it will continue to build its industrialized platform to enable drug discovery across the GPCR family and uncover novel mechanisms and new opportunities for previously difficult-to-drug GPCRs to address many diseases.

The company is creating broad new drug discovery opportunities across many disease areas for GPCRs. Septerna's proprietary native complex platform recapitulates GPCRs with their native structure, function, and dynamics outside of the cellular environment, which enables industrial-scale drug discovery using novel screening technologies and structure-based drug design.

The series A financing was led by Third Rock Ventures, with significant support from Samsara BioCapital, BVF Partners, Invus Financial Advisors, Catalio Capital Management, Casdin Capital, and Logos Capital.

Cytovation raises $20M in series A financing
Cytovation has successfully closed a series A financing round, raising a total of 180 million Norwegian krone ($20 million U.S.). The funds...
Verisim Life secures $15M series A funding
Verisim Life announced it has closed an oversubscribed $15 million series A financing round. Proceeds will help Verisim scale its operations, democratize...
Sosei Heptares enters agreement with Twist Bioscience
Twist Bioscience and Sosei Group have formed a strategic collaboration to discover therapeutic antibodies against G protein-coupled receptors identified...
Eurofins Scientific buys Beacon Discovery
Bioanalytical testing firm Eurofins Scientific has purchased Beacon Discovery, a contract research organization focused on G-protein coupled receptor...

Copyright © 2022 scienceboard.net


Conferences
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter